Lataa...
Engineering Chimeric Antigen Receptor T cells to Treat Glioblastoma
Immunotherapy has emerged as a promising strategy for glioblastoma (GBM), a disease that remains universally fatal despite currently available standard-of-care. Adoptive T cell therapy has been shown to produce potent antitumor immunity while obviating the need for traditional antigen presentation a...
Tallennettuna:
| Julkaisussa: | J Target Ther Cancer |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5695679/ https://ncbi.nlm.nih.gov/pubmed/29167820 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|